Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

TXG · ISSUER CIK 1770787

10x Genomics, Inc.

Between Aug 1, 2026 and Oct 29, 2026, 6 10x Genomics, Inc. insiders reported $0.00 of open-market purchases and $12.2M of sales on SEC Form 4.

SEC insider filings
↗6 insiders filed

Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 6 of 11 sales were reported under a 10b5-1 plan.

$0.00Insider buying
$12.2MInsider selling
−$12.2MNet open-market
Sep 24, 2026Latest filing
Form 4 trades at 10x Genomics, Inc.
TickerInsiderTypeOwned
Sep 24, 202616:30Sep 22, 2026TXGDirectorS · Sell10b5-1$81.19−5,72323,792-19%−$465K
Sep 24, 202616:29Sep 22, 2026TXGChief Executive Officer, DirectorS · Sell10b5-1$81.22−25,0001,050,249-2%−$2.0M
Sep 11, 202616:47Sep 9, 2026TXGChief Financial OfficerS · Sell10b5-1$64.57−46,388316,344-13%−$3.0M
Sep 8, 202619:00Sep 3, 2026TXGDirectorS · SellLate 5d$61.75−20,000328,436-6%−$1.2M
Sep 3, 202617:19Sep 1, 2026TXGChief Executive Officer, DirectorG · Gift—−1001,075,249-0%—
Aug 28, 202619:22Aug 26, 2026TXGChief Executive Officer, DirectorS · Sell10b5-1$63.69−10,4861,075,349-1%−$668K
Aug 26, 202616:46Aug 24, 2026TXGChief Executive Officer, DirectorS · Sell$63.02−18,5451,085,835-2%−$1.2M
Aug 26, 202616:44Aug 24, 2026TXGChief Financial OfficerS · Sell$63.02−17,166362,732-5%−$1.1M
Aug 26, 202616:43Aug 24, 2026TXGSee Remarks, DirectorS · Sell$63.02−13,818488,182-3%−$871K
Aug 26, 202616:42Aug 24, 2026TXGDirectorS · Sell10b5-1$63.65−2,20729,515-7%−$140K
Aug 24, 202616:16Aug 20, 2026TXGChief Executive Officer, DirectorG · Gift—−4,0001,104,380-0%—
Aug 17, 202616:08Aug 14, 2026from Aug 13, 2026TXGDirectorS · Sell10b5-1$57.25−7,55128,058-21%−$432K
Aug 13, 202616:11Aug 11, 2026TXGDirectorS · Sell$57.75−20,000348,436-5%−$1.2M
10x Genomics, Inc. (TXG) Insider Trading | Shameless Cloning